Loading…

Fifteen years of population based experience in Finland with a plasma-derived monoclonal purified factor VIII concentrate

Saved in:

Bibliographic Details
Published in:	Haemophilia : the official journal of the World Federation of Hemophilia 2008-05, Vol.14 (3), p.612-614
Main Authors:	MÄKIPERNAA, A., VON BONSDORFF, L.
Format:	Article
Language:	English
Subjects:	Adult Child Child, Preschool Coagulants - standards Coagulants - therapeutic use Factor VIII - standards Factor VIII - therapeutic use Finland - epidemiology Hemophilia A - drug therapy Hemophilia A - epidemiology Humans Product Surveillance, Postmarketing Virus Diseases - prevention & control Virus Diseases - transmission
Citations:	Items that this one cites
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

cited_by
cites	cdi_FETCH-LOGICAL-c3504-97be4752523be95a351c64725b531ae2bc9d65a2904e0b21e9cb02bdd1e7545f3
container_end_page	614
container_issue	3
container_start_page	612
container_title	Haemophilia : the official journal of the World Federation of Hemophilia
container_volume	14
creator	MÄKIPERNAA, A. VON BONSDORFF, L.
description
doi_str_mv	10.1111/j.1365-2516.2008.01674.x
format	article
fullrecord	<record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_69157521</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>69157521</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3504-97be4752523be95a351c64725b531ae2bc9d65a2904e0b21e9cb02bdd1e7545f3</originalsourceid><addsrcrecordid>eNqNkM1u1DAURi0EoqXwCsgrdkn9EzvJgkUpnXbUql20gMTGsp0b4SGJg520M2-P0xmVLd7Yss_3WfcghCnJaVqnm5xyKTImqMwZIVVOqCyLfPsKHb88vF7OgmYVo_IIvYtxQwjljMi36IhWnDIu2THarVw7AQx4BzpE7Fs8-nHu9OT8gI2O0GDYjhAcDBawG_DKDZ0eGvzkpl9Y47HTsddZk4jHxPZ-8Lbzg-7wOAfXunTXajv5gL-v12tsfaoZpqAneI_etLqL8OGwn6Bvq4uH86vs5u5yfX52k1kuSJHVpYGiFEwwbqAWOo1kZVEyYQSnGpixdSOFZjUpgBhGobaGMNM0FEpRiJafoE_73jH4PzPESfUuWujSFODnqGRNReqnCaz2oA0-xgCtGoPrddgpStSiXW3UYlctdtWiXT1rV9sU_Xj4YzY9NP-CB88J-LwHnlwHu_8uVldnF8sp5bN93sUJti95HX4rWfJSqB-3l-rhnn75efu1Utf8L1ILoT8</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>69157521</pqid></control><display><type>article</type><title>Fifteen years of population based experience in Finland with a plasma-derived monoclonal purified factor VIII concentrate</title><source>Wiley</source><creator>MÄKIPERNAA, A. ; VON BONSDORFF, L.</creator><creatorcontrib>MÄKIPERNAA, A. ; VON BONSDORFF, L.</creatorcontrib><identifier>ISSN: 1351-8216</identifier><identifier>EISSN: 1365-2516</identifier><identifier>DOI: 10.1111/j.1365-2516.2008.01674.x</identifier><identifier>PMID: 18312362</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>Adult ; Child ; Child, Preschool ; Coagulants - standards ; Coagulants - therapeutic use ; Factor VIII - standards ; Factor VIII - therapeutic use ; Finland - epidemiology ; Hemophilia A - drug therapy ; Hemophilia A - epidemiology ; Humans ; Product Surveillance, Postmarketing ; Virus Diseases - prevention & control ; Virus Diseases - transmission</subject><ispartof>Haemophilia : the official journal of the World Federation of Hemophilia, 2008-05, Vol.14 (3), p.612-614</ispartof><rights>2008 The Authors. Journal compilation © 2008 Blackwell Publishing Ltd</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c3504-97be4752523be95a351c64725b531ae2bc9d65a2904e0b21e9cb02bdd1e7545f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27905,27906</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18312362$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>MÄKIPERNAA, A.</creatorcontrib><creatorcontrib>VON BONSDORFF, L.</creatorcontrib><title>Fifteen years of population based experience in Finland with a plasma-derived monoclonal purified factor VIII concentrate</title><title>Haemophilia : the official journal of the World Federation of Hemophilia</title><addtitle>Haemophilia</addtitle><subject>Adult</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>Coagulants - standards</subject><subject>Coagulants - therapeutic use</subject><subject>Factor VIII - standards</subject><subject>Factor VIII - therapeutic use</subject><subject>Finland - epidemiology</subject><subject>Hemophilia A - drug therapy</subject><subject>Hemophilia A - epidemiology</subject><subject>Humans</subject><subject>Product Surveillance, Postmarketing</subject><subject>Virus Diseases - prevention & control</subject><subject>Virus Diseases - transmission</subject><issn>1351-8216</issn><issn>1365-2516</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><recordid>eNqNkM1u1DAURi0EoqXwCsgrdkn9EzvJgkUpnXbUql20gMTGsp0b4SGJg520M2-P0xmVLd7Yss_3WfcghCnJaVqnm5xyKTImqMwZIVVOqCyLfPsKHb88vF7OgmYVo_IIvYtxQwjljMi36IhWnDIu2THarVw7AQx4BzpE7Fs8-nHu9OT8gI2O0GDYjhAcDBawG_DKDZ0eGvzkpl9Y47HTsddZk4jHxPZ-8Lbzg-7wOAfXunTXajv5gL-v12tsfaoZpqAneI_etLqL8OGwn6Bvq4uH86vs5u5yfX52k1kuSJHVpYGiFEwwbqAWOo1kZVEyYQSnGpixdSOFZjUpgBhGobaGMNM0FEpRiJafoE_73jH4PzPESfUuWujSFODnqGRNReqnCaz2oA0-xgCtGoPrddgpStSiXW3UYlctdtWiXT1rV9sU_Xj4YzY9NP-CB88J-LwHnlwHu_8uVldnF8sp5bN93sUJti95HX4rWfJSqB-3l-rhnn75efu1Utf8L1ILoT8</recordid><startdate>200805</startdate><enddate>200805</enddate><creator>MÄKIPERNAA, A.</creator><creator>VON BONSDORFF, L.</creator><general>Blackwell Publishing Ltd</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200805</creationdate><title>Fifteen years of population based experience in Finland with a plasma-derived monoclonal purified factor VIII concentrate</title><author>MÄKIPERNAA, A. ; VON BONSDORFF, L.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3504-97be4752523be95a351c64725b531ae2bc9d65a2904e0b21e9cb02bdd1e7545f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Adult</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>Coagulants - standards</topic><topic>Coagulants - therapeutic use</topic><topic>Factor VIII - standards</topic><topic>Factor VIII - therapeutic use</topic><topic>Finland - epidemiology</topic><topic>Hemophilia A - drug therapy</topic><topic>Hemophilia A - epidemiology</topic><topic>Humans</topic><topic>Product Surveillance, Postmarketing</topic><topic>Virus Diseases - prevention & control</topic><topic>Virus Diseases - transmission</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>MÄKIPERNAA, A.</creatorcontrib><creatorcontrib>VON BONSDORFF, L.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Haemophilia : the official journal of the World Federation of Hemophilia</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>MÄKIPERNAA, A.</au><au>VON BONSDORFF, L.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Fifteen years of population based experience in Finland with a plasma-derived monoclonal purified factor VIII concentrate</atitle><jtitle>Haemophilia : the official journal of the World Federation of Hemophilia</jtitle><addtitle>Haemophilia</addtitle><date>2008-05</date><risdate>2008</risdate><volume>14</volume><issue>3</issue><spage>612</spage><epage>614</epage><pages>612-614</pages><issn>1351-8216</issn><eissn>1365-2516</eissn><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>18312362</pmid><doi>10.1111/j.1365-2516.2008.01674.x</doi><tpages>3</tpages></addata></record>
fulltext	fulltext
identifier	ISSN: 1351-8216
ispartof	Haemophilia : the official journal of the World Federation of Hemophilia, 2008-05, Vol.14 (3), p.612-614
issn	1351-8216 1365-2516
language	eng
recordid	cdi_proquest_miscellaneous_69157521
source	Wiley
subjects	Adult Child Child, Preschool Coagulants - standards Coagulants - therapeutic use Factor VIII - standards Factor VIII - therapeutic use Finland - epidemiology Hemophilia A - drug therapy Hemophilia A - epidemiology Humans Product Surveillance, Postmarketing Virus Diseases - prevention & control Virus Diseases - transmission
title	Fifteen years of population based experience in Finland with a plasma-derived monoclonal purified factor VIII concentrate
url	http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T21%3A05%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Fifteen%20years%20of%20population%20based%20experience%20in%20Finland%20with%20a%20plasma-derived%20monoclonal%20purified%20factor%20VIII%20concentrate&rft.jtitle=Haemophilia%20:%20the%20official%20journal%20of%20the%20World%20Federation%20of%20Hemophilia&rft.au=M%C3%84KIPERNAA,%20A.&rft.date=2008-05&rft.volume=14&rft.issue=3&rft.spage=612&rft.epage=614&rft.pages=612-614&rft.issn=1351-8216&rft.eissn=1365-2516&rft_id=info:doi/10.1111/j.1365-2516.2008.01674.x&rft_dat=%3Cproquest_cross%3E69157521%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3504-97be4752523be95a351c64725b531ae2bc9d65a2904e0b21e9cb02bdd1e7545f3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=69157521&rft_id=info:pmid/18312362&rfr_iscdi=true